Status: Recruiting
StrataMGT in the Reduction of Vulvar Lichen Sclerosus (LS) Symptoms
This study is designed to evaluate the efficacy and safety of StrataMGT for the management of vulvar lichen sclerosus symptoms.
Participants needed: 100
Trial details
Phase: Phase 1Age: 18+Biological sex: FemaleType: InterventionalSponsor: Andrew T. Goldstein, MDUpdated: Nov 8, 2024Locations: 3
Eligibility criteria
Female, 18 years or older. [+8]
Who are immunocompromised (e.g., lymphoma, AIDS, Wiskott-Aldrich Syndrome) or ha... [+6]